Jørgen Buus Lassen
Directeur/Membre du Conseil chez Effector A/S
Postes actifs de Jørgen Buus Lassen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Effector A/S
 Effector A/S Miscellaneous Commercial ServicesCommercial Services Effector A/S is a Danish company that specializes in creating effective health communication. The private company is based in Copenhagen, Denmark, and has subsidiaries in Norway. The company develop various exciting projects for their clients. | Directeur/Membre du Conseil | 11/08/2010 | - |
| Evalua A/S | Directeur/Membre du Conseil | 08/09/2011 | - |
| Collegium Internationale Neuro-Psychopharmacologicum | Corporate Officer/Principal | 08/09/2011 | - |
Historique de carrière de Jørgen Buus Lassen
Anciens postes connus de Jørgen Buus Lassen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NICOX SA | Directeur/Membre du Conseil | 09/10/2009 | 21/06/2013 |
Gudme Raaschou Invest A/S
 Gudme Raaschou Invest A/S Gudme Raaschou Invest A/S (GRI) is an investment management firm based in Copenhagen, Denmark. GRI is a wholly-owned subsidiary of Gudme Raaschou Asset Management Holding A/S, which is a wholly-owned subsidiary of Gudme Raaschou Bank A/S, and ultimately of Copenhagen-based Gudme Raaschou Holding A/S. The firm administers and distributes the Gudme Raaschou Health Care unit trust, as well as the Gudme Raaschou unit trust, which is composed of several compartments: Nordic Alpha, European Bonds, High Yield and US High Yield. Both unit trusts are managed by their affiliate, Gudme Raaschou Asset Management. | Directeur/Membre du Conseil | 11/08/2010 | 28/03/2011 |
| Gudme Raaschou Health Care | Président | 01/01/2003 | 01/01/2010 |
Pharmexa A/S
 Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration | Directeur/Membre du Conseil | - | 16/06/2009 |
NsGene A/S
 NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Président | 01/01/1999 | 01/06/2008 |
| NTG NORDIC TRANSPORT GROUP A/S | Directeur Technique/Scientifique/R&D | 01/01/1989 | 01/01/2008 |
| Fondateur | 01/01/1989 | 01/01/2008 | |
| ░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
Formation de Jørgen Buus Lassen
| University of Copenhagen | Doctorate Degree |
Statistiques
Internationale
| Danemark | 12 |
| Suède | 3 |
| France | 2 |
Opérationnelle
| Director/Board Member | 9 |
| Chairman | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 9 |
| Transportation | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| NICOX SA | Health Technology |
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| ZEALAND PHARMA A/S | Health Technology |
| EGETIS THERAPEUTICS AB | Health Technology |
| SPAGO NANOMEDICAL AB | Health Technology |
| Entreprise privées | 9 |
|---|---|
Pharmexa A/S
Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration | Health Technology |
Gudme Raaschou Invest A/S
Gudme Raaschou Invest A/S Gudme Raaschou Invest A/S (GRI) is an investment management firm based in Copenhagen, Denmark. GRI is a wholly-owned subsidiary of Gudme Raaschou Asset Management Holding A/S, which is a wholly-owned subsidiary of Gudme Raaschou Bank A/S, and ultimately of Copenhagen-based Gudme Raaschou Holding A/S. The firm administers and distributes the Gudme Raaschou Health Care unit trust, as well as the Gudme Raaschou unit trust, which is composed of several compartments: Nordic Alpha, European Bonds, High Yield and US High Yield. Both unit trusts are managed by their affiliate, Gudme Raaschou Asset Management. | |
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Health Technology |
Sophion Bioscience A/S
 Sophion Bioscience A/S Medical SpecialtiesHealth Technology Sophion Bioscience A/S develops, manufactures and markets instruments and supplies automated patch clamping. It develops throughput patch clamp solutions for functional characterization of living cells. The firm products are used in pharmaceutical and biotech companies around the world. The company was founded in July 2007 and is headquartered in Ballerup, Denmark. | Health Technology |
| Collegium Internationale Neuro-Psychopharmacologicum | |
Effector A/S
Effector A/S Miscellaneous Commercial ServicesCommercial Services Effector A/S is a Danish company that specializes in creating effective health communication. The private company is based in Copenhagen, Denmark, and has subsidiaries in Norway. The company develop various exciting projects for their clients. | Commercial Services |
| Gudme Raaschou Health Care | |
Scanbur A/S
 Scanbur A/S Medical SpecialtiesHealth Technology Scanbur A/S engages in the production and supply of housing, cage changing, cleaning, and decontamination equipment for animal research facilities. It also offers bedding and nesting materials, as well as air handling units. The company was founded on December 18, 1975 and is headquartered in Karlslunde, Denmark. | Health Technology |
| Evalua A/S |
- Bourse
- Insiders
- Jørgen Buus Lassen
- Expérience
